|Year : 2013 | Volume
| Issue : 3 | Page : 318-322
The effect of dexmedetomidine continuous infusion as an adjuvant to general anesthesia on sevoflurane requirements: A study based on entropy analysis
Chirag Ramanlal Patel, Smita R Engineer, Bharat J Shah, S Madhu
Department of Anesthesia, B. J. Medical College, Civil Hospital, Ahmedabad, India
|Date of Web Publication||27-Aug-2013|
Chirag Ramanlal Patel
No.22, Chirag Society, Opp. Ankur Bus stand, Ankur, Naranpura, Ahmedabad - 380 023
Source of Support: None, Conflict of Interest: None
Background: Dexmedetomidine, a α2 agonist as an adjuvant in general anesthesia, has anesthetic and analgesic-sparing property.
Aims: To evaluate the effect of continuous infusion of dexmedetomidine alone, without use of opioids, on requirement of sevoflurane during general anesthesia with continuous monitoring of depth of anesthesia by entropy analysis.
Materials and Methods: Sixty patients were randomly divided into 2 groups of 30 each. In group A, fentanyl 2 mcg/kg was given while in group B, dexmedetomidine was given intravenously as loading dose of 1 mcg/kg over 10 min prior to induction. After induction with thiopentone in group B, dexmedetomidine was given as infusion at a dose of 0.2-0.8 mcg/kg. Sevoflurane was used as inhalation agent in both groups. Hemodynamic variables, sevoflurane inspired fraction (FI sevo ), sevoflurane expired fraction (ET sevo ), and entropy (Response entropy and state entropy) were continuously recorded. Statistical analysis was done by unpaired student's t-test and Chi-square test for continuous and categorical variables, respectively. A P-value < 0.05 was considered significant.
Results: The use of dexmedetomidine with sevoflurane was associated with a statistical significant decrease in ET sevo at 5 minutes post-intubation (1.49 ± 0.11) and 60 minutes post-intubation (1.11 ±0.28) as compared to the group A [1.73 ±0.30 (5 minutes); 1.68 ±0.50 (60 minutes)]. There was an average 21.5% decrease in ET sevo in group B as compared to group A.
Conclusions: Dexmedetomidine, as an adjuvant in general anesthesia, decreases requirement of sevoflurane for maintaining adequate depth of anesthesia.
Keywords: Depth of anesthesia, dexmedetomidine, entropy, fentanyl, sevoflurane
|How to cite this article:|
Patel CR, Engineer SR, Shah BJ, Madhu S. The effect of dexmedetomidine continuous infusion as an adjuvant to general anesthesia on sevoflurane requirements: A study based on entropy analysis. J Anaesthesiol Clin Pharmacol 2013;29:318-22
|How to cite this URL:|
Patel CR, Engineer SR, Shah BJ, Madhu S. The effect of dexmedetomidine continuous infusion as an adjuvant to general anesthesia on sevoflurane requirements: A study based on entropy analysis. J Anaesthesiol Clin Pharmacol [serial online] 2013 [cited 2017 May 23];29:318-22. Available from: http://www.joacp.org/text.asp?2013/29/3/318/117066
| Introduction|| |
Alpha (α) 2 -adrenoceptor agonists have been used as adjuvant to anesthetic agents in peri-operative period for its several beneficial actions. These drugs improve hemodynamic stability during endotracheal intubation and surgical stress by its central sympatholytic action, and thus reduce anesthetic and opioids requirements. 
Dexmedetomidine, the pharmacologically active d-isomer of medetomidine, is highly selective and specific α2-adrenoceptor agonist. , The analgesic effect of dexmedetomidine is qualitatively different as compared to opioids and can be used as an alternative to opioids in general anesthesia. ,, The anesthetic sparing effect of dexmedetomidine demonstrated in earlier studies is confounded by the use of opioids. ,,,,,, Opioids, when used as analgesic in general anesthesia, are known to decrease MAC value of sevoflurane.  Inhalation agents were titrated based on either hemodynamic criteria and/or bispectral index values in studies done earlier, and none of them demonstrated the effect of dexmedetomidine alone on requirement of sevoflurane with the use of entropy as a measure of depth of anesthesia. ,,,,, The primary objective of our study was to evaluate the effect of continuous infusion of dexmedetomidine alone, without use of opioids, on sevoflurane requirement during general anesthesia with continuous monitoring of depth of anesthesia by entropy analysis.
| Materials and Methods|| |
The study protocol was approved by ethical committee of the institute, and written informed consent was obtained from all patients included in the study. The study population comprised of 60 patients, aged 18-55 years, with American Society of Anesthesiologists (ASA) status of 1 and 2, undergoing major elective surgical procedures. We excluded patients older than 55 years, those with a history of psychiatric/neurological illness, cardiovascular disease, hypertensive patients, morbid obese patients, pregnant and nursing women, with known allergic reaction to any of the study medication, recent use of sedatives or analgesics, and with significant laboratory abnormalities. The consenting patients were randomly allocated into one of the two anesthetic groups based on the simple randomization table generated: Group A (control group): Sevoflurane-fentanyl and group B (test group): Sevoflurane-dexmedetomidine.
After arrival in the operating room, glycopyrrolate 0.004 mg/kg and ondansetron 0.15 mg/kg intravenous (IV) were given as pre-medication in both the groups. The patients in group B received dexmedetomidine(2 ml diluted in 48 ml of saline) IV in a dose of 1 mcg/kg over10 minutes through infusion pump prior to induction. Monitoring consisted of continuous electrokardiogram (EKG), non-invasive blood pressure (NIBP), pulse oximetry (SpO 2 ), CO 2 expired fraction (ETCo 2 ), sevoflurane inspired fraction (FI sevo ), sevoflurane expired fraction (ET sevo ), and electroencephalograph (EEG) analysis by entropy (Response and State entropy). After the start of drug infusion, heart rate (HR), blood pressure (BP), respiratory rate (RR), SpO 2 , and entropy were measured at 5 th and 10 th minute. Patients in group A received fentanyl 2 μg/kg intravenous slowly, 2 minutes prior to induction.
After pre-oxygenation for 10 minutes, general anesthesia was induced with thiopentone sodium 5 mg/kg IV slowly. Endotracheal intubation was facilitated with succinylcholine 2 mg/kg IV. Anesthesia was maintained with oxygen: Nitrous-oxide (50:50) and sevoflurane. Vecuronium bromide was used as muscle relaxant.
In the group B, dexmedetomidine infusion was continued between 0.2 and 0.8 mcg/kg/h depending on HR, BP, and entropy value changes. Anesthesia was maintained with sevoflurane to a maximum of 2.5% end tidal to maintain heart rate and blood pressure within 20% of baseline value and entropy value between 40 and 60. The anesthesiologist was permitted to treat hemodynamic events, defined as heart rate and blood pressure more than 20% of baseline, in spite of increasing sevoflurane concentration to 2.5% and dexmedetomidine infusion to 0.8 mg/kg with supplemental analgesia in the form of fentanyl 1 mcg/kg. If rise in heart rate and blood pressure persisted further after supplementation with fentanyl, anesthesiologist was permitted to administer incremental doses of metoprolol 2-5 mg. Ephedrine 5 mg IV was given for fall in heart rate and blood pressure more than 20% of baseline.
In the group B, dexmedetomidine was stopped approximately 15-20 minutes before completion of surgery, diclofenac sodium aqueous 1 mg/kg was given IV in both groups at the time of skin closure. Nitrous oxide and sevoflurane were discontinued after skin closure in both groups. Reversal of neuromuscular blockade was achieved with neostigmine 0.05 mg/kg and glycopyrrolate 0.008 mg/kg IV slowly. Tracheal extubation was done when respiration was satisfactory and adequate muscle tone was achieved.
Statistical Analysis was conducted with Epi Info software (version 3.5.3, 2011, Centers for Disease Control and Prevention, Atlanta, GA, USA) for windows statistical package using unpaired t-test for continuous variables with normal distribution. The non-parametric Kruskal-Wallis test was used for variables not normally distributed. For categorical variables, Chi-square test was used. The results were expressed as mean ± SD. A P-value < 0.05 was considered as statistically significant.
- HR and BP were recorded before induction, at the time of induction, intubation, and then at 5, 10, 15, 30, 45, and 60 minute after intubation and at extubation.
- Depth of anesthesia was evaluated by entropy (State entropy, Response entropy) analysis (Datex-Ohmeda S/5 Avance workstation™ , GE Healthcare, Helsinki, Finland) at 5, 10, 15, 30, 45, and 60 minute after intubation and at extubation.
- End tidal concentration of sevoflurane was assessed with anesthesia gas assessment module E-CAiOVX™ at same interval as entropy analysis.
| Results|| |
A total of 60 patients enrolled in the study were included for statistical analysis. The two groups were similar regarding age, sex, weight, and ASA physical status [Table 1]. Laparoscopic cholecystectomy was the most frequent surgical procedure [Table 2].The duration of anesthesia was comparable between both the groups. Pre-induction heart rate, systolic and diastolic blood pressures were similar between two groups (P > 0.05).
The depth of anesthesia as assessed by response entropy (RE) and state entropy (SE) was comparable between two groups at all time points during maintenance period (P > 0.05). The RE and SE was maintained between 40 and 60 during the period of observation.
The FI sevo concentration was significantly less in group B as compared to the group A at all time points (P < 0.05) [Figure 1].The average ET sevo concentration during anesthetic maintenance was 1.35% and 1.72% in the group B and A, respectively. A significant decrease of 13% to 33% of ET sevo concentration was seen with group B from 5 min to 60 minutes post-intubation ( P < 0.05) during surgery [ [Figure 2].
|Figure 1: Fraction of inspired sevoflurane at different time interval (PI-post-intubation, FI-fraction of inspired)|
Click here to view
|Figure 2: End tidal sevoflurane at different time intervals (PI-post-intubation)|
Click here to view
During anesthesia maintenance, group B showed a statistical significant decrease in heart rate, systolic and diastolic blood pressure from baseline at all time points as compared to the group A (P < 0.05). An average 6.5% fall in heart rate from baseline in group B as compared to 3.7% rise in the group A, 8% fall in systolic blood pressure from baseline as compared to 3.6% rise in the group A, and 8.16% fall in diastolic blood pressure from baseline as compared to 3.3% rise in the group A was observed [Figure 3] and [Figure 4].
|Figure 3: Changes in SBP and DBP at various time points post-intubation (PI-post-intubation, SBP-systolic blood pressure, DBP-diastolic blood pressure)|
Click here to view
|Figure 4: Changes in HR at various time points post-intubation (PI-post intubation, HR-heart rate)|
Click here to view
In our study, none of the patients in either group required supplemental analgesia or anti-hypertensive drugs intra-operatively. Bradycardia was observed in 2 patients in group B within 10 mins post-extubation, which promptly responded to atropine 0.6 mg IV.
| Discussion|| |
The major observation in our study was that dexmedetomidine infusion as an adjuvant in general anesthesia causes decreased requirement of sevoflurane without compromising adequate depth of anesthesia, thus it has anesthetic-sparing property.
Anesthetic-sparing effect of dexmedetomidine in our study is consistent with earlier studies. A study done on patients undergoing hysterectomy showed a 30% reduction of maintenance concentration of isoflurane.  Similarly, a reduction in 35% to 50% in isoflurane concentration with low or high dose of dexmedetomidine was found in a study on healthy human volunteers.  This larger reduction in isoflurane requirement seen as compared to our study might be due to difference in study population (healthy human volunteers vs. patients posted for elective surgery) and the type of stimulus (tetanus nerve stimulus vs. surgical stimulus). The results of our study results are consistent with that of the study done by Fragen, et al . in elderly patients, which showed a 17% reduction.
Dexmedetomidine by its sympatholytic action decreases heart rate and blood pressure, thus assessing the depth of anesthesia by hemodynamic parameters would be unreliable in evaluating its effect on requirement of inhalational agent. Several electroencephalogram-dependent indices such as bispectral index and entropy have been used to measure the depth of anesthesia.  Entropy is a useful monitor for measuring the electroencephalographic effects of increasing and decreasing sevoflurane concentration and assessing the depth of anesthesia. , Analogous to the bispectral index, entropy displays a high degree of specificity and sensitivity in assessing consciousness during anesthesia. , Using bispectral index to assess the depth of anesthesia, Magalhγes et al. showed decreased requirement of sevoflurane with continuous infusion of dexmedetomidine during general anesthesia. In our study, we used entropy to measure the depth of anesthesia, thereby eliminating the bias of evaluation by hemodynamic parameters as in earlier studies.
Use of dexmedetomidine produces intra-operative and post-operative opioids-sparing effect. Dexmedetomidine by its sympatholytic action attenuates symapthoadrenal response to tracheal intubation.  In patients undergoing laparoscopic tubal ligation, a 33% decrease in morphine use post-operatively was observed when dexmedetomidine was used at a dose of 0.4 mcg/kg.  Dexmedetomidine when administered as infusion at a dose of 0.5 mcg/kg/h has specific analgesic effect and provides visceral pain relief.  In morbidly obese, dexmedetomidine produces a greater decrease in sympathovagal balance intra-operatively than fentanyl along with better post-operative analgesia.  Dexmedetomidine, when used as sole substitute for remifentanil in ambulatory gynecologic laparoscopic surgery, provides better peri-operative hemodynamic stability and post-operative analgesia.  Dexmedetomidine provides similar intra-operative hemodynamic response and better post-operative analgesia compared to remifentanil in patients undergoing supratentorial craniotomy. 
Use of fentanyl reduces minimum alveolar concentration (MAC) of sevoflurane significantly.  Use of opioids along with dexmedetomidine would confound its effect on requirement of inhalation agent. Hence, in our study, fentanyl was not administered in dexmedetomidine group B, and we found a 21.5% decrease in the ET sevo , in contrast to 33.12% decrease in study done by Magalhγes E et al. where fentanyl was used.
One limitation of our study was that we included both laparoscopic as well as open surgeries. Requirement of inhalational agent can be different in laparoscopic and open surgeries.
To conclude, the continuous infusion of dexmedetomidine, as adjuvant in general anesthesia, significantly decreases the requirement of sevoflurane for maintaining adequate depth of anesthesia. Studies measuring plasma concentration of dexmedetomidine should be undertaken to establish the precise correlation between its dose and inhalational agent's requirements.
| References|| |
|1.||Scholz J,Tonner PH. α2-Adrenoceptor agonists in anaesthesia: A new paradigm. Curr Opin Anaesthesiol 2000;13:437-42. |
|2.||Savola JM, Ruskoaho H, Puurunen J, Salonen JS, Kärki NT. Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors. J Auton Pharmacol 1986;6:275-84. |
|3.||Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14. |
|4.||Cortinez LI, Hsu YW, Sum-Ping ST, Young C, Keifer JC, Macleod D, et al. Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004;101:1077-83. |
|5.||Salman N, Uzun S, Coskun F, Salman MA, Salman AE, Aypar U. Dexmedetomidine as a substitute for remifentanil in ambulatory gynecologic laparoscopic surgery. Saudi Med J 2009;30:77-81. |
|6.||Techanivate A, Dusitkasem S, Anuwattanavit C. Dexmedetomidine compare with fentanyl for postoperative analgesia in outpatient gynecologic laparoscopy: A randomized controlled trial. J Med Assoc Thai 2012;95:383-90. |
|7.||Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705. |
|8.||Aantaa R, Jaakola ML, Antero K, Jussi K. Reduction of the Minimum Alveolar Concentration of Isoflurane by Dexmedetomidine. Anesthesiology 1997;86:1055-60. |
|9.||Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: The effect on recovery outcome variables. Anesth Analg 2008;106:1741-8. |
|10.||Aho M, Lehtinen AM, Erkola O, Kallio A, Korttila K. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology 1991;74:997-1002. |
|11.||Magalhães E, Govêia CS, Ladeira LC, Espíndola BV. Relationship between dexmedetomidine continuous infusion and end-tidal sevoflurane concentration, monitored by bispectral analysis. Rev Bras Anestesiol 2004;54:303-10. |
|12.||Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999;83:372-80. |
|13.||Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. J Clin Anesth 1999;11:466-70. |
|14.||Zhang Y, Hu X, Zhnag Y. Fentanyl reduces the MAC of sevoflurane. Zhonghua Yi Xue Za Zhi 1999;79:187-9. |
|15.||Ellerkmann RK, Liermann VM, Alves TM, Wenningmann I, Kreuer S, Wilhelm W, et al. Spectral entropy and bispectral index as measures of the electroencephalographic effects of sevoflurane. Anesthesiology 2004;101:1275-82. |
|16.||White PF, Tang J, Romero GF, Wender RH, Naruse R, Sloninsky A, et al. A comparison of state and response entropy versus bispectral index values during the perioperative period. Anesth Analg 2006;102:160-7. |
|17.||Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth 2011;55:352-7. |
|18.||Aho MS, Erkola OA, Scheinn H, Lehtinen AM, Korttila KT. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 1991;73:112-8. |
|19.||Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth 2006;18:24-8. |
|20.||Turgut N,Turkmen A, Ali A, Altan A. Remifentanil-propofol vs dexmedetomidine-propofol-anesthesia for supratentorial craniotomy. Middle East J Anesthesiol 2009; 20:63-70. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2]